Search Results - "Poulain, Stéphanie"
-
1
MYD88 L265P mutation in Waldenstrom macroglobulinemia
Published in Blood (30-05-2013)“…Mutation of the MYD88 gene has recently been identified in activated B-cell–like diffuse cell lymphoma and enhanced Janus kinase/signal transducer and…”
Get full text
Journal Article -
2
TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
Published in Clinical cancer research (15-10-2017)“…is a tumor-suppressor gene that functions as a regulator influencing cellular responses to DNA damage, and alterations are associated with pejorative outcome…”
Get full text
Journal Article -
3
High frequency of clonal hematopoiesis in Erdheim-Chester disease
Published in Blood (28-01-2021)“…Erdheim-Chester disease (ECD) is a clonal hematopoietic disorder characterized by the accumulation of foamy histiocytes within organs (in particular, frequent…”
Get full text
Journal Article -
4
Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia
Published in Clinical cancer research (15-03-2016)“…Whole-genome sequencing has revealed MYD88 L265P and CXCR4 mutations (CXCR4(mut)) as the most prevalent somatic mutations in Waldenström macroglobulinemia…”
Get full text
Journal Article -
5
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
Published in Haematologica (Roma) (01-01-2017)“…Bing Neel syndrome is a rare disease manifestation of Waldenström's macroglobulinemia that results from infiltration of the central nervous system by malignant…”
Get full text
Journal Article -
6
Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia
Published in Blood (11-03-2021)“…[Display omitted]…”
Get full text
Journal Article -
7
-
8
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome
Published in British journal of haematology (01-11-2014)“…Summary Bing‐Neel syndrome (BNS), a rare neurological syndrome associated with Waldenström macroglobulinaemia (WM), is a direct involvement of the central…”
Get full text
Journal Article -
9
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia
Published in Blood (24-06-2021)“…Conventional therapies for patients with T-cell prolymphocytic leukemia (T-PLL), such as cytotoxic chemotherapy and alemtuzumab, have limited efficacy and…”
Get full text
Journal Article -
10
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia
Published in Haematologica (Roma) (01-08-2021)Get full text
Journal Article -
11
Efficacy of ibrutinib in the treatment of Bing–Neel syndrome
Published in American journal of hematology (01-03-2016)Get full text
Journal Article -
12
Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells
Published in Frontiers in immunology (04-05-2021)“…Activating mutations of ( being the far most frequent) are found in most cases of Waldenström macroglobulinemia (WM) as well as in various aggressive B-cell…”
Get full text
Journal Article -
13
Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma
Published in British journal of haematology (01-07-2015)Get full text
Journal Article -
14
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots
Published in Human mutation (09-05-2023)“…TP53 aberrations are a major predictive factor of resistance to chemoimmunotherapy in chronic lymphocytic leukemia (CLL), and an assessment of them before each…”
Get full text
Journal Article -
15
-
16
Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia
Published in Hematology/oncology clinics of North America (01-10-2018)“…Waldenström macroglobulinemia is a rare indolent B-cell lymphoma. Whole-exome sequencing studies have improved our knowledge of the Waldenström…”
Get full text
Journal Article -
17
Mast cell density and its clinical relevance in Waldenström's macroglobulinemia
Published in EJHaem (01-05-2022)“…The presence of numerous mast cells (MCs) mixed with tumor cells in the bone marrow (BM) is a hallmark of the diagnosis of Waldenström's macroglobulinemia…”
Get full text
Journal Article -
18
Lenalidomide is safe and active in Waldenström macroglobulinemia
Published in American journal of hematology (01-11-2015)“…Lenalidomide is manageable and effective in multiple myeloma, particularly in elderly patients. Surprisingly, the combination of lenalidomide with rituximab…”
Get full text
Journal Article -
19
Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia
Published in American journal of hematology (01-11-2013)“…SNP array (SNPa) was developed to detect copy number alteration (CNA) and loss of heterozygosity (LOH) without copy number changes, CN‐LOH. We aimed to…”
Get full text
Journal Article -
20
Profuse telangiectasias in an immunocompetent patient misleading presentation revealing a hepatosplenic‐Tγδ‐cell lymphoma
Published in Clinical case reports (01-03-2022)“…Here we present the case of an hepato‐splenic‐Tγδ‐cell lymphoma interestingly occurring in a non‐immunocompromised patient, with profuse telangiectasias giving…”
Get full text
Journal Article